The investigational gene therapy SB-525Â is tolerated well by patients, and dose-dependent responses are positive, according to preliminary results of…
Diogo Pinto
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Diogo Pinto
The Royal College of Surgeons in Ireland (RCSI) and Bayer will collaborate to develop improved treatments for patients…
Pfizer has partnered with Spark Therapeutics to launch a Phase 3 program to evaluate the safety and effectiveness of…